Implanet SA - Asset Resilience Ratio
Implanet SA (ALIMP) has an Asset Resilience Ratio of 0.55% as of June 2021. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Implanet SA PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2013–2020)
This chart shows how Implanet SA's Asset Resilience Ratio has changed over time. See Implanet SA (ALIMP) net asset quality to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Implanet SA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see ALIMP market cap.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €93.00K | 0.55% |
| Total Liquid Assets | €93.00K | 0.55% |
Asset Resilience Insights
- Limited Liquidity: Implanet SA maintains only 0.55% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Implanet SA Industry Peers by Asset Resilience Ratio
Compare Implanet SA's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Inspire Medical Systems Inc
NYSE:INSP |
Medical Devices | 20.29% |
|
Shanghai General Healthy Information and Technology Co. Ltd.
SHG:605186 |
Medical Devices | 0.84% |
|
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033 |
Medical Devices | 19.31% |
|
Stratec SE
XETRA:SBS |
Medical Devices | 0.30% |
|
Duearity AB
ST:DEAR |
Medical Devices | 145.62% |
|
Anteris Technologies Global Corp
AU:AVR |
Medical Devices | 33.27% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 0.04% |
Annual Asset Resilience Ratio for Implanet SA (2013–2020)
The table below shows the annual Asset Resilience Ratio data for Implanet SA.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2020-12-31 | 1.47% | €128.00K ≈ $149.65K |
€8.70 Million ≈ $10.17 Million |
+0.66pp |
| 2019-12-31 | 0.81% | €78.00K ≈ $91.19K |
€9.65 Million ≈ $11.28 Million |
-2.88pp |
| 2018-12-31 | 3.68% | €326.00K ≈ $381.13K |
€8.85 Million ≈ $10.35 Million |
-4.31pp |
| 2017-12-31 | 7.99% | €1.00 Million ≈ $1.17 Million |
€12.56 Million ≈ $14.69 Million |
+5.01pp |
| 2016-12-31 | 2.98% | €490.74K ≈ $573.72K |
€16.46 Million ≈ $19.24 Million |
-29.61pp |
| 2015-12-31 | 32.59% | €5.31 Million ≈ $6.21 Million |
€16.29 Million ≈ $19.04 Million |
+30.47pp |
| 2014-12-31 | 2.12% | €308.12K ≈ $360.22K |
€14.55 Million ≈ $17.02 Million |
-6.25pp |
| 2013-12-31 | 8.36% | €2.00 Million ≈ $2.34 Million |
€23.92 Million ≈ $27.97 Million |
-- |
About Implanet SA
Implanet S.A., together with its subsidiaries, manufactures and sells implants and medical instruments for orthopedic surgery in France, the United States, Europe, the Middle East, Africa, and internationally. The company offers spinal and knee products, including Jazz PF, Jazz Evo, Jazz Cap SP, Jazz Passer, Jazz Lock, Jazz Claw, Olea, Saxxo, Swingo, Shark, Origin, and Jazz Frame, as well as ISS-… Read more